2B7J:F:F-iShares MSCI World SRI UCITS ETF USD (Dist) (EUR)

ETF | Others |

Last Closing

USD 8.34

Change

+0.12 (+1.44)%

Market Cap

N/A

Volume

N/A

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-03-20 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
SXR8:F iShares Core S&P 500 UCITS ETF..

-0.06 (-0.01%)

USD 108.00B
UIM5:F UBS (Lux) Fund Solutions - MSC..

N/A

USD 105.67B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

+0.04 (+0.06%)

USD 104.83B
XDNY:F Xtrackers MSCI Japan ESG Scree..

+0.03 (+0.20%)

USD 62.86B
VUSA:F Vanguard Funds Public Limited ..

N/A

USD 51.63B
SXRZ:F iShares VII PLC - iShares Nikk..

+0.45 (+0.19%)

USD 49.04B
XJSE:F Xtrackers II - Japan Governmen..

+0.07 (+0.89%)

USD 41.48B
0ZC:F Zscaler Inc

-0.30 (-0.16%)

USD 37.92B
BSND:F Danone SA

-0.10 (-0.71%)

USD 33.83B
VGWL:F Vanguard FTSE All-World UCITS ..

-0.76 (-0.60%)

USD 24.77B

ETFs Containing 2B7J:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -6.61% 18% F 35% F
Dividend Return -4.54% 16% F 1% F
Total Return -11.15% 8% B- 25% F
Trailing 12 Months  
Capital Gain 1.74% 37% F 50% F
Dividend Return -3.60% 6% D- N/A F
Total Return -1.86% 18% F 38% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 6.90% 57% F 57% F
Dividend Return 7.02% 55% F 50% F
Total Return 0.12% 9% A- 3% F
Risk Return Profile  
Volatility (Standard Deviation) 9.66% 70% C- 92% A
Risk Adjusted Return 72.64% 72% C 79% B-
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.